TABLE 2.

Key learning points

People with diabetes are at increased risk of severe disease and worse outcomes due to COVID‐19

Strict PPE use and hand hygiene must be encouraged

Monitoring of BGLs and ketones should be increased in unwell people with diabetes and COVID‐19 in hospital

People with diabetes and COVID‐19 must be closely monitored for signs of clinical deterioration

In people presenting with complications of diabetes (DKA/HHS) of unclear cause, consider testing for COVID‐19

People admitted with COVID‐19 infection should have HbA1c tested to ensure patients with undiagnosed diabetes are identified and appropriate glycaemic management is initiated

In people with diabetes and COVID‐19 admitted to hospital, consider withholding most oral hypoglycaemic agents and commencing insulin as required

Review sick day management plans and community care arrangements prior to discharge

Ensure follow‐up is arranged post‐discharge, particularly where medication changes have been made to ensure medications are restarted when appropriate

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.